CIK 0001400118
- Emerging growth company
Sagimet Biosciences Inc.
Sign in to watch- Ticker
- SGMT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 205991472
- Phone
- +1 650-561-8600
- Business address
- 950 TOWER LANE, STE 1500, FOSTER CITY, CA, 94404
- Former names
- 3-V Biosciences, Inc.
- 4 Open-market buy President & CEO bought 12,100 shares at $5.27 ($63,731)
- 3 Insider Initial Statement of Ownership
- 4 Other disposition 10% owner disposed of 1,110,950 shares (other)
- 4 Other disposition 10% owner disposed of 1,110,950 shares (other)
- 4 Other disposition 10% owner disposed of 1,110,950 shares (other)
- 4 Other disposition 10% owner disposed of 1,110,950 shares (other)
- 4 Other disposition 10% owner disposed of 850,000 shares (other)
- 4 Open-market buy President & CEO bought 1,600 shares at $4.10 ($6,560)
- 4 Grant or award General Counsel and CCO acquired 171,420 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 89,570 shares (grant or award)
- 4 Grant or award Executive Chairman acquired 150,750 shares (grant or award)
- 4 Grant or award President & CEO acquired 624,910 shares (grant or award)
- 4 Open-market buy President & CEO bought 590 shares at $2.35 ($1,387)
- 4 Exercise or conversion Executive Chairman acquired 5,630 shares (option exercise)
- 4 Open-market buy 10% owner bought 30,000 shares at $16.00 ($480,000)
- 4 Conversion 10% owner acquired 1,860,712 shares (conversion)
- 4 Open-market buy Director bought 46,875 shares at $16.00 ($750,000)
- 4 Conversion Director acquired 1,654,701 shares (conversion)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 4 of 5 · 100 filings